A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece

This study aimed to assess the cost-effectiveness of abobotulinumtoxinA (aboBoNT-A) plus Best Supportive Care (BSC) compared with BSC alone for managing limb spasticity in adult patients in Greece, as well as to conduct a budget impact analysis of the introduction of aboBoNT-A in the Greek healthcar...

Full description

Bibliographic Details
Main Authors: Nikolaos Nomikos, Christos Eleftheriou, Kostas Athanasakis
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Toxins
Subjects:
cost-effectiveness analysis
budget impact analysis
abobotulinumtoxinA
limb spasticity
Online Access:https://www.mdpi.com/2072-6651/15/9/561

Internet

https://www.mdpi.com/2072-6651/15/9/561

Similar Items